Prostate Cancer Awareness Month Presentation

Diagnostics and Therapeutics for Prostate Cancer: An Update
with Dr. Abby Collier
Wednesday, September 15th 7 pm Eastern

Prostate cancer (PCa) affects Canadian citizens widely and is one of the most common cancers diagnosed in either genders. As time has progressed we have become better at diagnosing and treating PCa. However scientific and medical efforts continue to push the boundaries of diagnosis and therapy. In this presentation, Dr Collier will present some of the newly approved diagnostics and therapeutics for PCa, including providing a broad overview of how these fields are developing from a research and clinical trial perspective.

Register now

About Dr. Abby Collier
Originally from New Zealand, Dr. Collier holds both a BSc and PhD in pharmacology from the University of Auckland. After a postdoctoral fellowship with Professor Chris Pritsos at the University of Nevada, Dr. Collier was an assistant professor, then associate professor at the University of Hawaii Medical School. A member of the Faculty of Pharmaceutical Sciences at UBC since 2013, Dr. Collier is professor of Drug Metabolism and Pharmacokinetics, teaches pharmacology to undergraduate, graduate, pharmacy and medical students, maintains an active and well-funded research lab and directs the new undergraduate BPSc degree program.

Dr. Collier’s sub-specialty is drug metabolism and pharmacokinetics. She is the winner of the 2021 Center for Alternatives to Animal Testing (CAAT) Award (biennial, world-wide) in recognition of her scientific research leading the field in modeling and simulation “to reduce, refine and replace animal use”. She uses a combination of laboratory work and computer modeling to improve drug/chemical safety and efficacy. Along with her collaborators, she also performs research and publishes regularly in the fields of human and environmental toxicology and endocrinology, including prostate cancer.

Register now

September 2021 Support Group Meeting

We hope you took some time this Summer to relax and recharge, and possibly even reaquaint with neighbours and friends. As we move into Fall, we still are not able to resume in person meetings at Hospice of Windsor & Essex County, due to COVID-19 related restrictions. Our Steering Committee has decided to suspend our Monthly Support Group Meetings until such time as we can resume meeting in person. We will continue to stay in touch and update you via these postings. Please feel free to contact us anytime at

September is Prostate Cancer Awareness Month. Please consider joining this presentation by Dr. Laurence Klotz.

Active Surveillance: Bench to Bedside
with Dr. Laurence Klotz
Thursday, September 9th, 7:30 pm Eastern

Don’t miss this special presentation from the incredible doctor who coined the term ‘Active Surveillance’ and has been working tirelessly for decades to reduce the overtreatment, morbidity, and mortality of prostate cancer. 

This is your chance to ask questions and chat with North America’s leading Active Surveillance expert.

Register now

About Dr. Laurence KlotzLaurence Klotz, CM, MD, FRCSC
Dr. Laurence Klotz was educated at the University of Toronto,  Canada, where in 1977 he obtained his MD. Dr. Klotz completed his residency at the University of Toronto in 1983.  Subsequently, he was a Fellow in Uro-Oncology and Tumor Biology at the Memorial Sloan Kettering Cancer Center in New York, completing it in 1985.
Dr. Klotz then  returned to Sunnybrook Health Sciences Centre in Toronto. He is an  Associate Scientist at the Sunnybrook Research Institute, past Chief of Urology, Professor of Surgery at the University of Toronto, and the Sunnybrook Chair of Prostate Cancer Research. 
Dr. Klotz is a widely published uro-oncologist (504 peer review publications, 6 books).  His basic  research interests have included research in the role of micronutrients and diet in prostate cancer prevention, and translational research in biomarkers and imaging. His research lab has been active for 30 years, producing several patents and a biotech company.  His clinical research interests have been in the areas of active surveillance, image guided therapy, molecular biomarkers, and androgen receptor targeted therapy.   He has led numerous randomized trials in prostate cancer.
Active surveillance was a concept pioneered under Dr. Klotz’s leadership.  He led the team at Sunnybrook who was the first to implement an approach to patients with low risk prostate cancer based on conservative management, with selective intervention for those patients who were diagnosed as higher risk over time. He coined the term ‘active surveillance’, and was responsible for promoting its acceptance by urological and radiation oncology communities worldwide. His drive to reduce the overtreatment, morbidity, and mortality of prostate cancer has led to over a hundred papers on this subject alone and numerous national and international invitations as a guest lecturer and visiting professor. In addition to his basic and clinical research endeavors, Dr. Klotz has initiated and participated in many professional organizations and societies.  In 1994, he founded the Canadian Journal of Urology, which was the officially endorsed journal of the Canadian Urological Association from 1996 to 2004. In 2005 he founded the Canadian Urology Association Journal in conjunction with the CUA, was Editor in Chief until 2010, and currently  is the CUAJ  Editor Emeritus. He has been Associate Editor of the Journal of Urology (Prostate Cancer) since 2014.  Since 2018 he has been the Managing Editor of the International Consultations on Urologic Diseases, and in 2020 this re-invigorated initiative produced the book ‘Molecular Biomarkers in Urologic Oncology’ under his leadership. 
Dr. Klotz established and chaired the Canadian Urology Consortium (CURC), a clinical research network,  in 2000 and the World Urologic Oncology Federation (WUOF), which brought the world’s regional and national Uro Oncology Societies together under one umbrella in 2002.  Originally 6, there are now 20 member societies.  
Dr. Klotz was awarded the Queen’s Jubilee Medal in 2013 for meritorious public service, and the University of Toronto Department of Surgery Lister Prize for outstanding research contributions and the Society of Urologic Oncology Medal in 2014.
In 2015 he received Canada’s highest civilian award, the Order of Canada, and the Harold Warwick Prize from the Canadian Cancer Society for international contributions to cancer control.  The AUA presented him the Richard Williams Award for outstanding contributions in urologic oncology in 2016.  He has received Lifetime Achievement Awards from the University of Toronto in 2017 and the Canadian Urological Association in 2019.  He also received the Huggins medal from the SUO in 2019.

Dr. Klotz is married to Ursula, and has 2 children, Alex, a professor of physics at California State in Los Angeles, and Betsy, a recreational therapist.  He founded ‘The Void’, an all-Urology Band in which he plays piano.  He has never received any awards for his tennis or ice hockey performance, both of which he plays frequently.

Register now

If you can’t make it on September 9th, don’t worry.  A recording of the presentation will be available on Prostate Cancer BC’s YouTube channel.

April 2021 Support Group Meeting

Please join us for our April Support Group Meeting via Zoom. We are pleased to bring you a video presentation by Dr. Danny Vesprini, Radiation Oncologist at Sunnybrook Health Sciences Centre, Toronto.

Dr. Vesprini is an assistant professor in the department of radiation oncology at the University of Toronto.

His clinical interests are in the treatment of prostate and testicular cancer, while his research interests include:

  • Prostate cancer prevention
  • Screening and treatment of BRCA1/BRCA2 mutation carriers
  • Identification of genetic biomarkers that predict aggressiveness and progression of prostate cancer in men followed on an active surveillance protocol.

In this “pre-COVID” presentation to Prostate Cancer Support Toronto, Dr. Vesprini dicusses “Active Surveillance Decisions (Why, Who, How, and When you know it’s time to be treated)”.

Time: April 13, 2021, 07:00 PM Eastern Time (US and Canada)

Join Zoom Meeting

Meeting ID: 873 9794 3362
Passcode: 728264

“The Prostate Cancer Support Windsor/Essex volunteer group and its members strictly provide news, non-medical peer support, and awareness information about prostate cancer.  Neither the group nor its members provide medical advice, diagnosis, or treatment.  Any related communications or interactions including website news, content, or information; group meetings; individual peer support discussions; public awareness briefings; conferences; brochures; or otherwise are NOT intended to be a substitute for professional medical advice, diagnosis, or treatment.  Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.  NEVER disregard professional medical advice or delay in seeking it because of communications or interactions received from our volunteer group or members.”

Prostate Cancer 101 Video

A plain talk discussion of Prostate Cancer featuring Denis in the starring role along with supporting performances by Jim, Don, Wayne, Noel and Greg. Surely worthy of award nominations!

Our thanks to Greg for coordinating and directing, and to Prostate Cancer Canada, Families First, Windsor Mold Group, Windsor Cancer Centre Foundation, WFCU Centre, and Windsor Spitfires for their support and participation.

Please feel free to share.

March 2020 Support Group Meeting

Photo courtesy of University of Windsor

For our March 10, 2020 Support Group Meeting, we were pleased to welcome our Guest Speaker, Lisa A. Porter, Ph.D. Professor, University of Windsor and Director, WE-SPARK Health Institute.

Dr. Porter received her Ph.D. in medical sciences from McMaster University, followed by a post-doctoral fellowship in chemistry & biochemistry from the University of California San Diego.  She joined the University of Windsor in 2004 as a Canadian Institutes of Health Research New Investigator.
Her research program covers many aspects of understanding how cancer begins and progresses to an aggressive, drug resistant state. The goal is finding new more effective therapies for patients. 
Dr. Porter described their research, focused on finding more effective ways to detect the progression of prostate cancer and treat aggressive, drug resistant stages of the disease.

Dr. Porter was also a founding director of the Windsor Cancer Research Group and this more recently has grown into a bone fide Health Research Institute, WE-SPARK Health Institute, to serve the needs of Windsor-Essex.  

She included a few slides to introduce the goals of WE-SPARK Health Institute and how this will benefit our Windsor-Essex community.

February 2020 Support Group Meeting

For our February 11th Support Group Meeting, we were pleased to welcome our Guest Speaker, MARC MARIER, who recounted his experience with prostate cancer as a young man at 40 years of age. We heard how Marc traveled to Houston, Texas for treatment.

With over thirty three years of experience Marc is the second generation operator of Marcels Collision. Beyond his vast knowledge of the collision repair process, Marc has a lot knowledge of the insurance industry and their the claims process.

He’ll help take the pain out of the repair process and help you get your car fixed as quickly and efficiently as possible.

Our meeting was also open for others, both men and women, to tell their story, including some of our members.

November 2019 Support Group Meeting

For our November Support Group Meeting, we welcomed our Guest Speaker, Dr. Tom Deklaj, MD, FRCSC.

Originally from Windsor, Dr. Deklaj obtained his Doctor of Medicine from the University of Toronto (2003) and performed his Internship and Urology Residency at Dalhousie University, Halifax. He is a Certified Specialist in Urology (2008) and also holds a Fellowship in Minimally Invasive Urology Laparoscopic and Robotic Surgery from the University of Chicago.

Dr. Deklaj is a Fellow of the Royal College of Physicians and Surgeons of Canada, an Endourological Society Fellow and a member of the Canadian Urological Association.

Dr. Deklaj spoke to us about Androgen Deprivation Therapy as it relates to the treatment of Prostate Cancer.

October 2019 Support Group Meeting

For our October Support Group Meeting, we welcomed back our Guest Speaker, Andrea Simone, who presented her findings regarding emotional needs of men diagnosed with prostate cancer.

Andrea received her BScN from the University of Windsor and has been employed full-time since 1991 at Henry Ford Hospital, in Detroit, MI. Her experience has been in the inpatient and outpatient care setting treating urology patients for twenty-four years specializing in post operative care for robotic radical prostatectomy patients. Most recently, in 2017, she accepted a position in the Quality and Safety department at Henry Ford Hospital, specifically specializing in Sepsis outcomes and education as it relates to Core Measure government data.

In 2006, she initiated and implemented the first educational group classes for couples recovering from prostate cancer treatments for the Vattikuti Urology Institute (VUI). The focus had been on continence and penile rehabilitation and assisting men and couples in attaining a full recovery after treatment for prostate cancer, therefore, enhancing quality of life. This teaching has been expanded to other communities including Windsor and various organizations both voluntarily and frequently as a guest speaker.

She enjoys being part of a team that provides comprehensive patient care and attention to psychosocial-emotional needs of patients and their significant others. Andrea has been a guest speaker for TIMM medical, Ambulatory Nurse Council, St. Clair College, Windsor-Essex County Prostate Cancer Support Group, and the Urology Nurses of Canada (UNC) in Ottawa (2014).

No Support Group Meetings in July or August

Just a reminder that we don’t hold Support Group meetings in July or August. Our next meeting will be Tuesday, September 10th @ 7:00 pm at Hospice of Windsor-Essex County. Further details will follow.

Newly diagnosed and need support now? Follow this link to our website:

Enjoy your Summer!

June 2019 Support Group Meeting

For our June 2019 Support Group Meeting, we welcomed our guest speaker Tim Brady, Pharmacist and Owner of Brady’s Drug Stores in Essex and Belle River.

Tim was elected to the Ontario Pharmacists Association (“OPA”) Board of Directors as a District Representative in June 2016.  He has been a member of the OPA Insurance Committee since 2013 and has been a Board member with the Essex County Pharmacists Association since 2005 (he served as President from 2010-12).

A graduate of Ferris State University with a BS in Pharmacy, Tim is the pharmacist owner of two independent pharmacies in Essex County. Prior to opening his own pharmacy, Tim worked locally as a Pharmacist for a number of years.

Tim was the lead pharmacist in the “We Can Quit” program for smoking cessation, and a member of the 2011 Rotary District 6400 Vocational Training Team to East Timor.

His talk covered topics such as “Medical Cannabis as an Aid in Prostate Cancer” and the latest medicines related to Prostate Cancer, Incontinence, and Erectile Dysfunction.  Our thanks to Tim Brady for this down to earth talk on Sex, Life, and Prostate Cancer.


Get every new post delivered to your Inbox

Join other followers: